This work is aimed at evaluating the effect of repeated intracavernosal injection (ICI) self-injection on the peak systolic velocity (PSV) and the diameter of cavernosal arteries. Sixty erectile dysfunction (ED) patients who were positive responders for ICI therapy were studied. Pharmacopenile duplex ultrasonography (PPDU) was carried out before starting ICI and after 10 doses of home therapy in an open-label uncontrolled study. There was significant increase in the cavernosal artery diameter and their PSV before and after injection. Cavernosal arteries diameter before injection in both right and left sides was 0.6470.13 and 0.6370.12 mm at the start and became 0.8170.22 and 0.7970.22 mm respectively at the end with significant differences (Po0.001). Cavernosal arteries diameter after injection in both right and left sides was 1.1070.18 and 1.0970.19 mm at the start and became 1.3470.39 and 1.2770.33 mm respectively at the end with significant differences (Po0.001). PSV at the start was 33.77713.26 and 32.3378.09 cm/s on both right and left sides and became 44.471.19 and 46.175.86 cm/s respectively at the end with significant differences (Po0.001). It is concluded that repeated ICI improves arterial erectile response with associated increase in PSV and cavernosal artery diameters.
Introduction
Erectile dysfunction (ED) affects 1 in every 100 men and is estimated to affect about 150 million men worldwide. 1 Penile erection is produced by increased blood flow to the corpora cavernosa (CC) made by the opening of penile resistance vessels (helicine arteries), relaxation of CC sinusoids and occlusion of the venous outflow. 2 The erectile response depends on nitric oxide (NO), produced by nerves and by vascular endothelium. 3 The era of intracavernosal injection (ICI) for diagnosing and treating ED began with the pioneer report of Virag 4 dating the first pharmacologically induced penile erection introducing papaverine hydrochloride as a substance capable of inducing erection. After this event, additional substances were introduced for ICI treatment: phentolamine mesylate, prostaglandin E 1 (PGE 1 ) and vasoactive peptide. [5] [6] [7] ICI is also used as a preliminary step in vascular investigations such as pharmacopenile duplex ultrasonography (PPDU), which is a minimally invasive technique used to diagnose vasculogenic ED. 8, 9 Patients on ICI self-injection therapy should regularly consult their treating physicians on a monthly basis, to evaluate the condition and observe any complications or improvement. Penile ultrasonography is performed to verify any clinical findings on digital palpation of the penis. 10 In this study, evaluation of the effect of repeated ICI self-injection was aimed at both the peak systolic velocity (PSV) and the diameters of cavernosal arteries using PPDU.
Materials and methods
Sixty ED patients who were positive responders for ICI therapy were included in this study after IRB approval. Initial assessment of the cases included history taking and general and genital examinations (penile, scrotal and per-rectal). The patients were given their ICI in the outpatient clinic and the responses were assessed according to Gerstenberg et al.: 11 E 0 , no response; E 1 , slight tumescence; E 2 , no rigidity; E 3 , medium tumescence; E 4 , medium rigidity; E 5 , full tumescence.
Drug used for ICI was initially 1 ml of bimix (papaverine hydrochloride 30 mg/ml and phentolamine mesylate 1 mg/ml). 12 If non-satisfactory response was obtained, the dose was increased to 2 ml. If non-satisfactory response was obtained again, quadrimix (12.1 mg/ml papaverine hydrochloride, phentolamine mesylate 1.01 mg/ml, PGE 1 10.1 mg/ ml, atropine sulfate 0.15 mg/ml) 13 was used in increasing doses of 0.5-2.0 ml according to the response. A good response was defined as the ability to attain and maintain an erection sufficient for sexual intercourse (E 4 -E 5 ) for 15 min. Nonresponders were excluded from the study.
Duplex examination was carried out in all cases at the beginning of the study, where PSV and cavernosal artery diameter were reported. The drug formula used for ICI during duplex examination was the same drug and dose that resulted in good response during initial assessment. PPDU was performed by a single well-trained andrologist using a single-color Doppler ultrasound (Esaote Biomedica AU3, Italy) with a 7.5 MHz linear array transducer with a color flow mapping capability.
Good responders of ICI were trained to self-inject according to the accepted regulations. 10 These cases were asked to use the ICI regularly (1-2 times/week) 15 min before sexual intercourse. All cases were followed up after 10 sessions of ICI home therapy after a period ranging from 24 h to 7 days from the last ICI injection. It included clinical examination to evaluate the response to ICI as well as to detect complications. PPDU was re-performed for comparison of PSV and cavernosal artery diameter before and after repeated self-injection. During follow-up PPDU, the data of the initial PPDU were not provided to the operator to prevent bias.
Statistical analysis
Data were presented in terms of range, standard deviation and percentages. Paired t-test was used to evaluate the mean change from the baseline to each point in the post-injection PSV and the mean change in arterial diameter of each cavernosal artery before and after injection.
Results
The mean age of the investigated cases (n ¼ 60) was 4779.05 years (range 32-65 years). Forty-eight cases (80%) received bimix for self-injection (22 cases used 1 ml and 26 used 2 ml), while 12 cases (20%) received quadrimix (8 cases used 0.5 ml, 2 cases used 1 ml and 2 cases used 2 ml). Six cases demonstrated marked improvement in the clinical response to ICI after completing the course by having successful sexual intercourse without ICI in 50% of their sexual activity. Twenty-two cases showed improvement in the clinical response (E5) after finishing the 10 doses of ICI self-injection ( 
in the PSV and cavernosal artery diameter. The percentage of clinical improvement of erection was significantly higher among cases 50 years old (81.3%) compared to cases 450 years old (57.1%) with significant difference (Po0.001). The adverse effects of repeated ICI were few: pain (20%), burning sensation (6.6%), mild fibrosis at injection site (3.3%) and prolonged erection (3.3%).
There was statistical significant difference between cavernosal artery diameter and PSV before and after injection (Table 1) .
Discussion
Erectile dysfunction is defined as the consistent or recurrent inability to obtain and/or maintain a penile erection sufficient for sexual activity. Erection is a vascular phenomenon under a psychoneurological control and situated in a hormonal environment. A variety of treatment options are available to the clinician, including medical, psychological and surgical treatments. 14 The role of ICI therapy in promoting a return of spontaneous erections is still controversial. Previous studies have reported return of erectile ability with ICI in 2/29 cases (7%), 15 2/111 cases (2%) 16 and 3/35 cases (9%). 17 One of the largest comprehensive reviews 18 The most optimistic in terms of spontaneous erections is the report of Virag et al., 19 which evaluated 466 patients on ICI therapy for dependency. They found that 37% were totally dependant, 49% were partially dependant and 14% were totally independent.
This study showed return of spontaneous erection during sexual activity in 10% of cases. This figure is in agreement with the studies of Ravnik-Oblak et al., 15 Bennett et al. 16 and Gerber and Levine 17 including nearly equal numbers of patients to ours. The study of Virag et al. 19 showed higher improved percentage, which may be due to the higher number of patients and the fact that their study included mainly psychogenic ED cases.
Marshall et al. 20 performed duplex ultrasonography on 35 ED patients before and after an average of 31 months of ICI therapy and compared the results with those of 10 controls. Cavernosal arterial diameter did not change significantly in either groups, but PSV was significantly increased from baseline in the treated group, with no change in the untreated one. The results of this study were in agreement with Marshall et al. in terms of PSV. However, we found a significant increase in the arterial diameter both before and after ICI, which may be explained by the fact that most of Marshall's study cases had an element of arteriogenic ED etiology.
The improvement in erectile function during or after ICI therapy was explained by various mechanisms: 18 (1) psychological relief of performance anxiety; (2) improved cavernous hemodynamics responses due to cavernosal arterial dilatation and/ or mechanical stretching of cavernous and tunical tissues producing improved tissue compliance and corporo-venous occlusive efficiency; (3) angiogenesis and neovascularization of cavernous tissue induced by PGE 1 injection; (4) improved oxygenation of cavernous tissue during induced erections, reducing collagenization and fibrosis; (5) hypertrophy of cavernous smooth muscle resulting in enhanced efficiency of cavernous physiology; (6) normal episodic fluctuations in erectile function related to variations in stress, general health, medication or partner factors.
Actually, since efficacious oral phosphodiesterase (PDE) inhibitors became available, management of male ED has dramatically improved. Notwithstanding the observation that most ED cases can be managed by oral drug therapy, there will still be a considerable number of candidates for self-injection therapy. 21, 22 Hatzichristou et al. 23 demonstrated that 30-40% of patients satisfied with long-term selfinjection therapy will stay on this therapy despite the emergence of new PDE inhibitors. Richter et al. 24 indicated that ICI therapy is still the gold standard for treating ED in elderly men. Nagai et al. 25 showed that ICI is effective in ED cases not responding to PDE inhibitors.
It is concluded that repeated ICI leads to improved arterial response with increased PSV and cavernosal arterial dilatation. A drawback of our study was that it was uncontrolled; however, the high significance of the results may support its validity.
